BioPharma Credit PLC
BOPCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.1B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.10 Billion |
|---|---|
| Enterprise Value | $1.03 Billion |
| Annual dividend | $0.13 |
| Dividend yield | 8.62% |
| Earnings per Share | $0.11 |
| Beta | 0.1 |
| Outstanding Shares | 1,129,227,778 |
Return
| Return on Equity | 20.25% |
|---|---|
| Return on Assets | 20.19% |
| Return on Invested Capital | 3.21% |
Valuation & Multiples
| P/E Ratio | 10.28 |
|---|---|
| PEG | -33.42 |
| Price to Sales | - |
| Price to Book Ratio | 0.93 |
| Enterprise Value to Revenue | 4.24 |
| Enterprise Value to EBIT | 28.19 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioPharma Credit PLC
15 employees
CEO: Pedro Gonzalez de Cosio
Operating as an investment trust since its founding in 2016 in Exeter, United Kingdom, BioPharma Credit PLC concentrates its investments on interest-bearing debt assets. These assets are financially backed by royalties or other revenue derived from the sales of established life sciences products.